v3.26.1
Investment in equity accounted investees (Details 1)
₨ in Millions, $ in Millions
12 Months Ended
Mar. 31, 2026
INR (₨)
Mar. 31, 2026
USD ($)
Mar. 31, 2025
INR (₨)
Mar. 31, 2024
INR (₨)
Mar. 31, 2026
USD ($)
Mar. 31, 2023
INR (₨)
Investments accounted for using equity method [Line Items]            
Ownership 51.30% 51.30% 51.30%      
Current assets ₨ 301,975   ₨ 250,112   $ 3,219  
Non-current assets 277,371   242,877   2,956  
Total assets 579,346   492,989   6,175  
Equity 380,457   337,166 ₨ 280,550 4,054 ₨ 230,991
Liabilities 167,566   130,392   1,787  
Total equity and liabilities 579,346   492,989   6,175  
Revenues 335,933 [1] $ 3,580 325,535 [1] 279,164 [1]    
Profit for the year 42,466 452 57,245 55,684    
Company's share of profits for the year 134 $ 1 217 ₨ 147    
Carrying value of the Company's investment ₨ 5,673   ₨ 4,811   $ 60  
Kunshan Rotam Reddy Pharmaceuticals Co Limited [Member]            
Investments accounted for using equity method [Line Items]            
Ownership 51.30% 51.30% 51.30% 51.30%    
Current assets ₨ 7,794   ₨ 6,551 ₨ 6,447    
Non-current assets 5,448   4,514 3,799    
Total assets 13,242   11,065 10,246    
Equity 9,942   8,273 7,692    
Liabilities 3,301   2,792 2,554    
Total equity and liabilities 13,242   11,065 10,246    
Revenues 8,339   9,317 9,688    
Expenses 8,031   8,892 9,396    
Profit for the year 308   425 292    
Company's share of profits for the year 158   218 150    
Carrying value of the Company's investment [2] 5,263   4,428 4,130    
Translation adjustment arising out of translation of foreign currency balances ₨ 1,229   ₨ 552 ₨ 472    
[1] Revenues for the year ended March 31, 2026 do not include inter-segment revenues from the PSAI segment to the Global Generics segment, of Rs.7,270 (as compared to Rs.9,389 and Rs.10,707 for the years ended March 31, 2025 and 2024, respectively) and from the PSAI segment to the Others segment of Rs.0 (as compared to Rs.0 and Rs.72 for the years ended March 31, 2025 and 2024, respectively)
[2] Includes Rs.181 representing the goodwill on acquisition of investment.